We appreciate the testimonials and references we have received from our satisfied customers and partners.

This for our consultancy and our interim management in pharmaceuticals, biotechnology, medical technology.

Hannes Schmeil, Managing Director of ALNYLAM Germany:

"... I can recommend S&P to all decision-makers with a clear conscience if they are not looking for "off-the-shelf" consulting and analysis offers, but are interested in tailor-made solutions - ones that can also be implemented operationally and actually work!"

Thomas Krause, Managing Director, Brandenburg Capital/ILB:

 "... The 3-year activity of the interim CEO/CFO at S&P was characterized at all times by focusing on the interests of the shareholders and investors and always being competent and hands-on".

Dr. Müller-Kuhrt, CEO Analyticon Discovery GmbH:

"... We can unreservedly recommend the involvement of S&P (Dr. Mertens) to any company in the life sciences industry that has to or wants to actively deal with the validation of its strategy and the associated adjustment of process flows or realignment of the organization and key actions." .

Franz Schenkel, M.B.A., CEO HSA Americas:

"...To this day, I admire your ability to combine tenacious analytical and strategic thinking with your unique demeanor, navigating complex organizational environments with professional and personal integrity, and - perhaps most importantly - your genuine personal collaboration with your team as well as internally colleagues and external partners".

Prof. Dr. legal Walter L Rust, LLM:

"...The collaboration was characterized by mutual trust, and I can recommend S&P and Dr. Mertens at any time for the support of life science companies."

Burkhard Kröger, CEO GPE Group:

"With the 3-year assumption of the function of an interim CEO for one of our customers, Dr. Mertens from S&P has actively and with leadership accepted and implemented the role as responsible planner, strategist and negotiator for a complex and innovative telemedical treatment system. I can work together with Dr. Mertens, S&P, recommend to every provider, as long as a professional, competent and timely solution of complex tasks is required".

Frank Michalak, Chairman of the Board of Directors of AOK Nordost:

"Dr. Mertens from S&P is a professional and is characterized by a very focused and goal-oriented way of working. His experience made a significant contribution to the start-up company EMPERRA being able to implement the pilot project with the AOK Nordost. Even if difficulties arose , he has managed in the 3 1/2 years of cooperation to make the process a success through his profitable human nature".

Dr. Andreas Baltrusch (former Chairman of the Board / CEO of CODON AG):

"S&P intensively accompanied a necessary change process within co.don AG over a period of 18 months. The overall project was divided into well-structured sub-projects by Dr. Horst Mertens with a clearly very experienced handwriting. S&P, under the leadership of Dr ". Mertens and Dr. Schneider delivered very pragmatic proposals for a future-proof expansion and process structure. I would hire him and the S&P team again if necessary and can highly recommend S&P to other decision-makers in the life sciences industry as a management consultancy and management coach ".